Merieux Institute Report issue

For profit Phase 4
Founded: Lyon France (1897)
Status: Acquired by Pasteur Merieux (1989) → now Sanofi-Aventis (2004)

Organization Overview

First Clinical Trial
1999
NCT00002069
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BIOAGRI Laboratórios Ltda | Institut Mérieux

Active Ingredients

Drugs in Phase 4 Trials (1)

procaine benzylpenicillin (novocaine) (1 trial)

Drugs in Other Trials (1)

thiocarb (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2